These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36556331)

  • 1. Impact of Left Ventricular Assist Devices on Days Alive and Out of Hospital in Hemodynamically Stable Patients with End-Stage Heart Failure: A Propensity Score Matched Study.
    Tenge T; Roth S; M'Pembele R; Lurati Buse G; Boenner F; Ballázs C; Tudorache I; Boeken U; Lichtenberg A; Neukirchen M; Huhn R; Aubin H
    Life (Basel); 2022 Nov; 12(12):. PubMed ID: 36556331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective comparison of mid-term outcomes in patients treated with heart transplantation with advanced age donors versus left ventricular assist device implantation.
    Ammirati E; Cipriani MG; Varrenti M; Colombo T; Garascia A; Cannata A; Pedrazzini G; Benazzi E; Milazzo F; Oliva F; Gagliardone MP; Russo CF; Frigerio M
    Interact Cardiovasc Thorac Surg; 2016 Oct; 23(4):584-92. PubMed ID: 27245619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left ventricular assist devices: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2004; 4(3):1-69. PubMed ID: 23074453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging roles of left ventricular assist device therapy as bridge to transplant in an Asian city with scarce heart transplant donor.
    Wong KL; Ho KLC; Lee OJ; Lun KS; Bhatia I; Tam WYE; Fan YYK; Au WKT
    J Thorac Dis; 2021 Oct; 13(10):5717-5730. PubMed ID: 34795921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term heart transplant outcomes after lowering fixed pulmonary hypertension using left ventricular assist devices.
    Moayedifar R; Zuckermann A; Aliabadi-Zuckermann A; Riebandt J; Angleitner P; Dimitrov K; Schloeglhofer T; Rajek A; Laufer G; Zimpfer D
    Eur J Cardiothorac Surg; 2018 Dec; 54(6):1116-1121. PubMed ID: 29905775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complications of left ventricular assist devices causing high urgency status on waiting list: impact on outcome after heart transplantation.
    Immohr MB; Boeken U; Mueller F; Prashovikj E; Morshuis M; Böttger C; Aubin H; Gummert J; Akhyari P; Lichtenberg A; Schramm R
    ESC Heart Fail; 2021 Apr; 8(2):1253-1262. PubMed ID: 33480186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of new-generation intrapericardial continuous flow left ventricular assist devices as a bridge-to-transplant.
    Carrozzini M; Bejko J; Gambino A; Tarzia V; Lanera C; Gregori D; Gerosa G; Bottio T
    J Cardiovasc Med (Hagerstown); 2018 Dec; 19(12):739-747. PubMed ID: 30300244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Continuous Flow Left Ventricular Assist Device on Heart Transplant Candidates: A Multi-State Survival Analysis.
    Carrozzini M; Bottio T; Caraffa R; Bejko J; Bifulco O; Guariento A; Lombardi CM; Metra M; Azzolina D; Gregori D; Fedrigo M; Castellani C; Tarzia V; Toscano G; Gambino A; Jorgji V; Ferrari E; Angelini A; Gerosa G
    J Clin Med; 2022 Jun; 11(12):. PubMed ID: 35743495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation.
    Clegg AJ; Scott DA; Loveman E; Colquitt J; Hutchinson J; Royle P; Bryant J
    Health Technol Assess; 2005 Nov; 9(45):1-132, iii-iv. PubMed ID: 16303098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulsatile left ventricular assist device support as a bridge to decision in patients with end-stage heart failure complicated by pulmonary hypertension.
    Nair PK; Kormos RL; Teuteberg JJ; Mathier MA; Bermudez CA; Toyoda Y; Dew MA; Simon MA
    J Heart Lung Transplant; 2010 Feb; 29(2):201-8. PubMed ID: 20113910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Days Alive and Out of the Hospital After Ventricular Assist Device Implantation With Adverse Events and Quality of Life.
    Noly PE; Wu X; Hou H; Grady KL; Stewart JW; Hawkins RB; Yang G; Kim KD; Zhang M; Cabrera L; Aaronson KD; Pagani FD; Likosky DS;
    JAMA Surg; 2023 Apr; 158(4):e228127. PubMed ID: 36811897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Days alive and out of hospital after left ventricular assist device implantation.
    Roth S; M'Pembele R; Stroda A; Voit J; Lurati Buse G; Sixt SU; Westenfeld R; Polzin A; Rellecke P; Tudorache I; Hollmann MW; Boeken U; Akhyari P; Lichtenberg A; Huhn R; Aubin H
    ESC Heart Fail; 2022 Aug; 9(4):2455-2463. PubMed ID: 35513994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One-Year Clinical Outcome in End-Stage Heart Failure: Comparison of "High Urgent" Listing for Heart Transplantation with Mechanical Circulatory Support Implantation.
    Sunavsky J; Zittermann A; Oezpeker C; Fujita B; Fuchs U; Gummert JF; Schulz U
    Thorac Cardiovasc Surg; 2015 Dec; 63(8):647-52. PubMed ID: 26177226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of functional capacity in patients with end-stage heart failure following implantation of a left ventricular assist device versus heart transplantation: results of the experience with left ventricular assist device with exercise trial.
    Jaski BE; Lingle RJ; Kim J; Branch KR; Goldsmith R; Johnson MR; Lahpor JR; Icenogle TB; Piña I; Adamson R; Favrot LK; Dembitsky WP
    J Heart Lung Transplant; 1999 Nov; 18(11):1031-40. PubMed ID: 10598726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of early versus delayed timing of left ventricular assist device implantation as a bridge-to-transplantation: An analysis of the UNOS dataset.
    Kitada S; Schulze PC; Jin Z; Clerkin K; Homma S; Mancini DM
    Int J Cardiol; 2016 Jan; 203():929-935. PubMed ID: 26618255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrovascular and microvascular function after implantation of left ventricular assist devices in end-stage heart failure: Role of microparticles.
    Sansone R; Stanske B; Keymel S; Schuler D; Horn P; Saeed D; Boeken U; Westenfeld R; Lichtenberg A; Kelm M; Heiss C
    J Heart Lung Transplant; 2015 Jul; 34(7):921-32. PubMed ID: 25980571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mid-term survival after continuous-flow left ventricular assist device versus heart transplantation.
    Ammirati E; Oliva FG; Colombo T; Russo CF; Cipriani MG; Garascia A; Guida V; Colombo G; Verde A; Perna E; Cannata A; Paino R; Martinelli L; Frigerio M
    Heart Vessels; 2016 May; 31(5):722-33. PubMed ID: 25735775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ventricular assist devices as bridge to heart transplantation in cardiogenic shock or terminal heart failure--12 years experience at the Sheba Medical Center].
    Lavee J; Kassif Y; Freimark D; Har Zahav Y; Koman V; Preisman S; Smolinsky A; Raanani E
    Harefuah; 2007 Nov; 146(11):833-6, 911. PubMed ID: 18087826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left Ventricular Device Implantation Impacts on Hospitalisation Rates, Length of Stay and Out of Hospital Time.
    Prichard R; Kershaw L; Goodall S; Davidson P; Newton P; McNeil F; Homer T; Hayward C
    Heart Lung Circ; 2018 Jun; 27(6):708-715. PubMed ID: 28888837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Proposal for updated listing criteria for heart transplantation and indications to implant of left ventricular assist devices].
    Ammirati E; Oliva F; Colombo T; Botta L; Cipriani M; Cannata A; Verde A; Turazza FM; Russo CF; Paino R; Martinelli L; Frigerio M
    G Ital Cardiol (Rome); 2013 Feb; 14(2):110-9. PubMed ID: 23389313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.